Skip to main content

$0.310 0.030 (10.71%)

High

$0.31

Low

$0.29

Trades

582

Turnover

$291,413

Volume

965,700
30 June 2023 at 4:10pm
Register to track SPL and receive email alerts.
Subject
SPL Ann: Clinical Trial Update

SPL Ann: Life Sciences Investor Forum Presentation

SPL Ann: Starpharma to present at Life Sciences Investor Forum

SPL Ann: AZD0466 Clinical Data Presented by AstraZeneca EHA Congress

SPL Ann: Starpharma CEO to retire in 2024

SPL Ann: VIRALEZE Nasal Spray Approved in Malaysia

SPL Ann: Application for quotation of securities - SPL

SPL Ann: Quarterly Activities/Appendix 4C Cash Flow Report

SPL Ann: HER2-targeted DEP SN38 ADC outperforms in HER2 cancer model

SPL Ann: AZD0466 active in small cell lung cancer patient models

SPL Ann: DEP cabazitaxel Ph 2 trial completes enrolment & treatment

SPL Ann: Commencement of CFO and Company Secretary

SPL Ann: Starpharma presents at ASX Small and Mid-Cap Conference

SPL Ann: Application for quotation of securities - SPL

SPL Ann: CFO and Company Secretary Appointment

SPL Ann: Interim Report and Half-Year Financial Results

SPL Ann: Dr Russell Basser appointed as director and Appendix 3X

SPL Ann: Change in substantial holding

SPL Ann: Change in substantial holding

SPL Ann: Application for quotation of securities - SPL

SPL Ann: Appointment of Company Secretary

SPL Ann: Dr Russell Basser appointed as non-executive director

SPL Ann: Quarterly Activities Report & Appendix 4C

SPL Ann: Response to ASX Query Letters

SPL Ann: Starpharma receives $7.1M R&D tax incentive refund

SPL Ann: Resignation of CFO / Company Secretary

SPL Ann: VIRALEZE Nasal Spray Registered in Indonesia

SPL Ann: Positive AZD0466 clinical data presented by AstraZeneca

SPL Ann: VIRALEZE Post-Market Clinical Study in COVID-19 Patients

SPL Ann: Change in Director's Interest Notice - J Fairley

SPL Ann: Notification regarding unquoted securities - SPL

SPL Ann: Retirement of non-executive Director

SPL Ann: AGM Results

SPL Ann: AGM Chairman address and CEO presentation

SPL Ann: VIRALEZE launched in Hong Kong and Macau

SPL Ann: Starpharma to present at Bell Potter Healthcare Conference

SPL Ann: Change in Director's Interest Notice - R Thomas

SPL Ann: Change in Director's Interest Notice - J Fairley

SPL Ann: Notice of Annual General Meeting/Proxy Form

SPL Ann: Application for quotation of securities - SPL

SPL Ann: Notification regarding unquoted securities - SPL

SPL Ann: Quarterly Activities Report & Appendix 4C

SPL Ann: VIRALEZE distribution agreement for Hong Kong and Macau

SPL Ann: Change in substantial holding

SPL Ann: Change in Director's Interest Notice - J Fairley

SPL Ann: Notification of cessation of securities - SPL

SPL Ann: Board Renewal

SPL Ann: 2022 Annual General Meeting Date

SPL Ann: Starpharma to present at Life Sciences Investor Forum

SPL Ann: Change in substantial holding

Register to track SPL and receive email alerts.

Similar Companies

CAN
CPH
EOF
IHL
MVP
MYX
NEU
PBP
RCE